{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/20/3276901/0/en/NewcelX-Updates-Corporate-Presentation-to-Highlight-Type-1-Diabetes-Flagship-Program-Following-Strategic-Collaboration-with-Eledon-Pharmaceuticals-Ahead-of-Swiss-Biotech-Conference.html", "message": "News view counter 671069 successfully enlarged"}